4.6 Article

Diabetic Choroidopathy: Choroidal Vascular Density and Volume in Diabetic Retinopathy With Swept-Source Optical Coherence Tomography

Journal

AMERICAN JOURNAL OF OPHTHALMOLOGY
Volume 184, Issue -, Pages 75-83

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajo.2017.09.030

Keywords

-

Categories

Funding

  1. MILLER RETINA RESEARCH FOUNDATION (MEE)
  2. Miller Champalimaud Award (MEE)
  3. Portuguese Foundation for Science and Technology/Harvard Medical School Portugal Program [HMSP-ICJ/006/2013]

Ask authors/readers for more resources

PURPOSE: To compare choroidal vascular density (CVD) and volume (CVV) in diabetic eyes and controls, using en face swept-source optical coherence tomography (SS-OCT). DESIGN: Prospective cross-sectional study. METHODS: SETTING: Multicenter. PATIENT POPULATION: Total of 143 diabetic eyes-27 with no diabetic retinopathy (DR), 47 with nonproliferative DR (NPDR), 51 with NPDR and diabetic macular edema (DME), and 18 with proliferative DR (PDR) and 64 age-matched nondiabetic control eyes. OBSERVATION PROCEDURES: Complete ophthalmologic examination and SS-OCT imaging. En face SS-OCT images of the choroidal vasculature were binarized. MAIN OUTCOME MEASURES: CVD, calculated as the percent area occupied by choroidal vessels in the central macular region (6-mm diameter circle centered on the fovea), and throughout the posterior pole (12 x 9 mm). The central macular CVV was calculated by multiplying the average CVD by macular area and choroidal thickness (obtained with SS-OCT automated software). Multilevel mixed linear models were performed for analyses. RESULTS: Compared to controls (0.31 +/- 0.07), central macular CVD was significantly decreased by 9% in eyes with NPDR + DME (0.28 +/- 0.06; B = -0.03, P = .02) and by 15% in PDR (0.26 +/- 0.05; B = -0.04, P = .01). The central macular CVV was significantly decreased by 19% in eyes with PDR (0.020 +/- 0.005 mm(3), B = 0.01, P = .01) compared to controls (0.025 +/- 0.01 mm(3)). CONCLUSIONS: Choroidal vascular density and volume are significantly reduced in more advanced stages of diabetic retinopathy. New imaging modalities should allow further exploration of the contributions of choroidal vessel disease to diabetic eye disease pathogenesis, prognosis, and treatment response. ((C) 2017 Published by Elsevier Inc.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available